"3+7"
Sponsors
Chinese PLA General Hospital
Conditions
Acute Myeloid LeukemiaFirst Line Therapy
Phase 2
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
CompletedNCT06068621
Start: 2023-03-01End: 2025-08-31Updated: 2026-01-20
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
RecruitingNCT06928376
Start: 2024-04-18End: 2026-09-01Target: 160Updated: 2026-05-08